Methods and compositions for treating B-cell malignancies | Patent Publication Number 20230074759
US 20230074759 A1Publication DateMar 9, 2023
Original AssigneeJohnson & Johnson
Current AssigneeJanssen Pharmaceuticals Johnson & Johnson
Inventor/ApplicantsMarco Vincent Haselager
A. P. Kater
Ulrike Philippar
Eric Frederik Eldering
Andrew Steele
Karoline Kielbassa
Ulrike PHILIPPAR
Eric Frederik ELDERING
Karoline KIELBASSA
Marco Vincent HASELAGER
A.P. KATER
Andrew STEELE
A. P. Kater
Ulrike Philippar
Eric Frederik Eldering
Andrew Steele
Karoline Kielbassa
Ulrike PHILIPPAR
Eric Frederik ELDERING
Karoline KIELBASSA
Marco Vincent HASELAGER
A.P. KATER
Andrew STEELE
Empower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.